Hosted on MSN3h
Moderna Q4 Earnings and Revenues Beat, COVID Vaccine Sales Decline
Moderna MRNA incurred a loss of $2.50 per share in the fourth quarter of 2024, narrower than the Zacks Consensus Estimate of ...
pulmonologyadvisor6h
RSV Infection in Young Children Associated With High Primary Care Burden
RSV infection that is managed via primary care in children under 5 years of age leads to a substantial burden for families, primary care resources, and society.
Parents Warned Over 'Quad-demic' of COVID, Flu, Norovirus and RSV
The U.S. has seen earlier and more intense surges of the flu and RSV this year than is typical, pediatrician Dr. Ryan Fulton ...
denver78h
Peak RSV season shifting back to when it was prior to pandemic, Children's Hospital Colorado doctor says
RSV season is in full swing, according to doctors at Children’s Hospital Colorado. Denver7 spoke with a local family that is all too familiar with the infection.
Moderna posts bigger loss than expected as vaccine maker scales down manufacturing
Moderna reported a bigger-than-expected quarterly loss on Friday, hit by a charge related to its efforts to scale down ...
Lehigh Valley seeing highest flu rates in Pa. during one of the worst seasons in years
In addition, more people died in Pennsylvania from the flu over the last two reporting periods than died of COVID-19, data ...
Moderna beats on revenue but loses more than expected as it scales down manufacturing
It marks another quarter of growing pains for the company, which is racing to launch new products and recover from the decline of its Covid business.